Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -22.18%. However, over the past six months, we’ve seen a stronger performance of -16.87%. The price of NUVB fallen by 5.61% over the last 30 days. And in the last five days, it has surged by 2.48%.
In terms of market performance, Nuvation Bio Inc had a fairly uneven. The highest value for the stock in the past year was $3.97 on 07/31/24, and the lowest value was recorded at $1.54 on 04/07/25.
52-week price history of NUVB Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Nuvation Bio Inc’s current trading price is -47.86% away from its 52-week high, while its distance from the 52-week low is 34.42%. The stock’s price range during this period has varied between$1.54 and $3.97. The Nuvation Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.09 million for the day, a figure considerably lower than their average daily volume of 2.69 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Nuvation Bio Inc (NUVB) has experienced a quarterly decline of -21.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 703.12M and boasts a workforce of 220 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.33, with a change in price of -0.78. Similarly, Nuvation Bio Inc recorded 2,658,656 in trading volume during the last 100 days, posting a change of -26.82%.
NUVB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
NUVB Stock Stochastic Average
Nuvation Bio Inc’s raw stochastic average for the past 50 days is presently 65.34%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 84.56%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 85.76% and 83.37%, respectively.
